☰

Yoshua Esquenazi - Publications

Affiliations: 
Neurosurgery University of Texas Houston Medical School, Houston, TX, United States 
Tree Info Similar researchers PubMed Report error

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wang DH, Fujita Y, Dono A, Rodriguez Armendariz AG, Shah M, Putluri N, Pichardo-Rojas PS, Patel CB, Zhu JJ, Huse JT, Parker Kerrigan BC, Lang FF, Esquenazi Y, Ballester LY. The genomic alterations in glioblastoma influence the levels of CSF metabolites. Acta Neuropathologica Communications. 12: 13. PMID 38243318 DOI: 10.1186/s40478-024-01722-1  0.385
2022 Kata K, Rodriguez-Quintero JC, Arevalo OD, Zhang JJ, Bhattacharjee MB, Ware C, Dono A, Riascos-Castaneda R, Tandon N, Blanco A, Esquenazi Y, Ballester LY, Amsbaugh M, Day AL, Zhu JJ. BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 1193-1202.e6. PMID 36351333 DOI: 10.6004/jnccn.2022.7046  0.348
2021 Dono A, Mitra S, Shah M, Takayasu T, Zhu JJ, Tandon N, Patel CB, Esquenazi Y, Ballester LY. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma. Journal of Neuro-Oncology. PMID 33881725 DOI: 10.1007/s11060-021-03755-1  0.414
2021 Shah M, Takayasu T, Zorofchian Moghadamtousi S, Arevalo O, Chen M, Lan C, Duose D, Hu P, Zhu JJ, Roy-Chowdhuri S, Riascos RF, Chen H, Luthra R, Esquenazi Y, Ballester LY. Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies. The Journal of Molecular Diagnostics : Jmd. 23: 171-180. PMID 33531134 DOI: 10.1016/j.jmoldx.2020.10.013  0.353
2021 Patrizz A, Dono A, Zhu P, Tandon N, Ballester LY, Esquenazi Y. Tumor recurrence or treatment-related changes following chemoradiation in patients with glioblastoma: does pathology predict outcomes? Journal of Neuro-Oncology. PMID 33481149 DOI: 10.1007/s11060-020-03690-7  0.342
2021 Kata K, Quintero JCR, Arevalo-Espejo O, Bhattacharjee MB, Ware C, Dono A, Riascos-Castaneda R, Tandon N, Blanco A, Esquenazi Y, Ballester LY, Amsbaugh M, Day AL, Zhu J. INNV-06. BRAF AND MEK DUAL INHIBITORS THERAPY IN RECURRENT OR ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA (PXA) Neuro-Oncology. 23: vi106-vi106. DOI: 10.1093/neuonc/noab196.418  0.359
2020 Xia H, Avci NG, Akay Y, Esquenazi Y, Schmitt LH, Tandon N, Zhu JJ, Akay M. Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation. Ieee Open Journal of Engineering in Medicine and Biology. 1: 9-16. PMID 35402955 DOI: 10.1109/OJEMB.2019.2962801  0.311
2020 Xia H, Avci NG, Akay Y, Esquenazi Y, Schmitt LH, Tandon N, Zhu JJ, Akay M. Temozolomide in Combination With NF-κB Inhibitor Significantly Disrupts the Glioblastoma Multiforme Spheroid Formation. Ieee Open Journal of Engineering in Medicine and Biology. 1: 9-16. PMID 35402955 DOI: 10.1109/OJEMB.2019.2962801  0.311
2020 Lopez-Rivera V, Dono A, Abdelkhaleq R, Sheth SA, Chen PR, Chandra A, Ballester LY, Esquenazi Y. Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location. Clinical Neurology and Neurosurgery. 199: 106282. PMID 33045626 DOI: 10.1016/j.clineuro.2020.106282  0.321
2020 Takayasu T, Shah M, Dono A, Yan Y, Borkar R, Putluri N, Zhu JJ, Hama S, Yamasaki F, Tahara H, Sugiyama K, Kurisu K, Esquenazi Y, Ballester LY. Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors. Scientific Reports. 10: 14326. PMID 32868820 DOI: 10.1038/S41598-020-71161-0  0.356
2020 Dono A, Zhu P, Holmes E, Takayasu T, Blanco A, Hsu S, Bhattacharjee M, Zhu J, Ballester LY, Esquenazi Y, Tandon N. SURG-23. REOPERATION IN MOLECULAR SUBTYPES OF RECURRENT GLIOBLASTOMA Neuro-Oncology. 22: ii208-ii208. DOI: 10.1093/neuonc/noaa215.870  0.349
2020 Dono A, Alfaro-Munoz K, Yan Y, Lopez-Garcia C, Soomro Z, Williford G, Takayasu T, Robell L, Majd N, de Groot J, Esquenazi Y, Kamiya-Matsuoka C, Ballester LY. PATH-19. MOLECULAR, HISTOLOGIC AND CLINICAL CHARACTERISTICS OF OLIGODENDROGLIOMAS: A MULTI-INSTITUTIONAL RETROSPECTIVE STUDY Neuro-Oncology. 22: ii168-ii168. DOI: 10.1093/neuonc/noaa215.701  0.379
2020 Aaroe A, Dono A, Youssef M, Alfaro-Munoz K, Weathers S, O’Brien B, Majd N, Harrison R, Loghin M, Soomro Z, Williford G, Fuller G, Yung WKA, Yeboa D, Esquenazi Y, et al. PATH-05. A RETROSPECTIVE STUDY OF TREATMENT STRATEGIES AND OUTCOMES IN WHO GRADE II AND III ISOCITRATE DEHYDROGENASE (IDH) WILD-TYPE ASTROCYTOMA Neuro-Oncology. 22: ii164-ii165. DOI: 10.1093/neuonc/noaa215.687  0.307
2020 Dono A, Mitra S, Takayasu T, Zhu J, Tandon N, Esquenazi Y, Ballester LY. BIOM-48. PTEN MUTATIONS PREDICT BENEFIT FROM TUMOR-TREATING FIELDS THERAPY IN PATIENTS WITH RECURRENT GLIOBLASTOMA Neuro-Oncology. 22: ii11-ii12. DOI: 10.1093/neuonc/noaa215.045  0.426
2019 Hovinga KE, McCrea HJ, Brennan C, Huse J, Zheng J, Esquenazi Y, Panageas KS, Tabar V. EGFR amplification and classical subtype are associated with a poor response to bevacizumab in recurrent glioblastoma. Journal of Neuro-Oncology. PMID 30680510 DOI: 10.1007/S11060-019-03102-5  0.33
2019 Shah M, Zorofchian S, Lan C, Duose D, Hu P, Zhu J, Luthra R, Esquenazi Y, Ballester LY. CMET-29. DETECTING TUMOR MUTATIONS IN CEREBROSPINAL FLUID: LIQUID BIOPSY FOR THE DIAGNOSIS OF CENTRAL NERVOUS SYSTEM METASTASES Neuro-Oncology. 21: vi57-vi58. DOI: 10.1093/neuonc/noz175.230  0.342
2018 Zorofchian S, Lu G, Zhu JJ, Duose DY, Windham J, Esquenazi Y, Ballester LY. Detection of the p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma. Frontiers in Oncology. 8: 382. PMID 30294590 DOI: 10.3389/fonc.2018.00382  0.303
2018 Ballester LY, Lu G, Zorofchian S, Vantaku V, Putluri V, Yan Y, Arevalo O, Zhu P, Riascos RF, Sreekumar A, Esquenazi Y, Putluri N, Zhu JJ. Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors. Acta Neuropathologica Communications. 6: 85. PMID 30170631 DOI: 10.1186/s40478-018-0588-z  0.372
2015 Esquenazi Y, Friedman E, Liu Z, Zhu J, Hsu S, Tandon N. Surg-12The Sub-Pial Resection Technique For Supra-Maximal Resection Of Glioblastomas Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov235.12  0.311
Show low-probability matches.